SCHEMBL14217523

SCHEMBL14217523

COc1ccc(COc2ccc(-c3noc(CC(NC(=O)OC(C)(C)C)C(=O)n4nc(O)c5ccccc54)n3)nc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 4/20 0.38
HCAR2 Q8TDS4 2/20 0.37
BCL2 P10415 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BRD4 O60885 1/20 0.35
CACNA1B Q00975 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GHSR Q92847 1/20 0.35
PSMB1 P20618 5/20 0.35
PSMB9 P28065 4/20 0.35
PSMB5 P28074 4/20 0.35
PSMB10 P40306 4/20 0.35
PSMB2 P49721 4/20 0.35
PSMB8 P28062 3/20 0.35
HDAC8 Q9BY41 1/20 0.35
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
F2 P00734 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13250478 0.89 HCAR2 (0.44) HCAR2
SCHEMBL13225534 0.87 HCAR2 (0.38) PTPN1HCAR2NPC1RAB9ASMN1; SMN2
SCHEMBL14217522 0.83 PPARA (0.48) PTPN1HCAR2BCL2NPC1RAB9A
SCHEMBL14217521 0.79 CACNA1B (0.41) PTPN1BCL2NPC1RAB9ASMN1; SMN2
SCHEMBL13225537 0.74 HCAR2 (0.47) HCAR2
SCHEMBL13225492 0.73 HCAR2 (0.56) HCAR2
SCHEMBL13250886 0.72 HCAR2 (0.49) PTPN1HCAR2
SCHEMBL4548463 0.71 CYP4F2 (0.53) HCAR2NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL13225536 0.70 PTPN1 (0.43) PTPN1HCAR2NPC1RAB9ASMN1; SMN2
SCHEMBL4548432 0.70 HCAR2 (0.49) PTPN1HCAR2NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008051403-A2 NIACIN RECEPTOR AGONISTS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT MERCK & CO., INC. (US) 2008-05-02 WO disclosed